News
23h
Clinical Trials Arena on MSNCognition Therapeutics’ drug shows 129% cognitive decline arrest in mild Alzheimer’s"Cognition Therapeutics’ drug shows 129% cognitive decline arrest in mild Alzheimer’s" was originally created and published ...
Alpha Cognition's ZUNVEYL targets Alzheimer's with improved tolerability over existing galantamine therapies. Read why I rate ...
The Alzheimer's Association U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) ...
Walking and other lifestyle habits may slow cognitive decline in APOE ε4 carriers — possibly offering greater benefits than ...
Experts say A.I. companions like Sunny have the potential to help keep the brain active and alleviate loneliness in dementia ...
A structured lifestyle program targeting multiple risk factors significantly improves cognitive function in older adults at risk for cognitive decline, outperforming a self-guided program.
Cognition is acquiring Windsurf days after Google DeepMind hired its CEO and research leaders, and months after OpenAI ...
Days after AI coding startup Windsurf announced that it’s being acquired by Cognition, Windsurf exec Jeff Wang took to X to ...
AI startup Cognition on Monday said it’s acquiring Windsurf in a deal that will include the coding company’s IP and user base ...
Artificial intelligence startup Cognition AI on Monday agreed to acquire Windsurf, an integrated development environment ...
Cognition acquires AI coding startup Windsurf, gaining its IP, talent, and user base, strengthening its position to compete ...
Cognition is seeking to achieve a jaw-dropping $10B valuation as investors race to back the next big thing. Can its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results